FDA Inspection
Anshi Pharmaceutical (Zhongshan) Inc.Anshi Pharmaceutical (Zhongshan) Inc. – FDA Inspection, Oct 27, 2017
Record Details
This FDA Inspection record concerns Anshi Pharmaceutical (Zhongshan) Inc., with an inspection on October 27, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3bc27a1f-511b-4bbd-8a31-de9c950fc7c7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031944
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Anshi Pharmaceutical (Zhongshan) Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 31, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Anshi Pharmaceutical (Zhongshan) Inc.
- FDA Inspection 920920 - 2015-03-20
- FDA Inspection 823594 - 2012-10-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.